|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
5
|
|
pubmed:dateCreated |
2007-5-14
|
|
pubmed:abstractText |
In diffuse parenchymal lung diseases, the evolution of pulmonary fibrosis is often devastating and may result in death. In this study the role of CCL18 as a biomarker of disease activity in idiopathic interstitial pneumonias (IIPs) and systemic sclerosis (SSc) with lung involvement was evaluated.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
May
|
|
pubmed:issn |
0004-3591
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
56
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1685-93
|
|
pubmed:meshHeading |
pubmed-meshheading:17469163-Adult,
pubmed-meshheading:17469163-Aged,
pubmed-meshheading:17469163-Aged, 80 and over,
pubmed-meshheading:17469163-Biological Markers,
pubmed-meshheading:17469163-Bronchoalveolar Lavage,
pubmed-meshheading:17469163-Bronchoalveolar Lavage Fluid,
pubmed-meshheading:17469163-Case-Control Studies,
pubmed-meshheading:17469163-Cells, Cultured,
pubmed-meshheading:17469163-Chemokines, CC,
pubmed-meshheading:17469163-Female,
pubmed-meshheading:17469163-Gene Expression Regulation,
pubmed-meshheading:17469163-Humans,
pubmed-meshheading:17469163-Lung Diseases, Interstitial,
pubmed-meshheading:17469163-Male,
pubmed-meshheading:17469163-Middle Aged,
pubmed-meshheading:17469163-Pulmonary Fibrosis,
pubmed-meshheading:17469163-Scleroderma, Systemic,
pubmed-meshheading:17469163-Severity of Illness Index
|
|
pubmed:year |
2007
|
|
pubmed:articleTitle |
CCL18 as an indicator of pulmonary fibrotic activity in idiopathic interstitial pneumonias and systemic sclerosis.
|
|
pubmed:affiliation |
University Hospital Freiburg, Freiburg, Germany. prasse@medizin.ukl.uni-freiburg.de
|
|
pubmed:publicationType |
Journal Article
|
